newsfilter
← Latest News
GlobeNewswire·

GeoVax Receives Notice of Allowance for HIV Vaccine Patent

ATLANTA, GA, Oct. 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today